Company news
Krystal Biotech, Inc. news in 2019
Krystal Biotech, Inc.'s news releases, calls and decks from 2019, newest first.
Krystal Biotech to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019
Krystal Biotech Reports Third Quarter 2019 Financial and Operating Results
November 3, 2019
Krystal Biotech Announces Final Update from Phase 1/2 Clinical Trial of KB103 ("bercolagene telserpavec," "B-VEC")
October 28, 2019
Krystal Biotech Receives Positive EMA Opinion on Orphan Designation for KB105 to Treat Patients With TGM1 Deficient Autosomal Recessive Congenital Ichthyosis
October 9, 2019
Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardan's 3rd Annual Genetic Medicines Conference
September 29, 2019
Krystal Biotech Announces Granting of its First Foreign Patent and Reinforces its IP Portfolio with a New U.S. Patent
September 26, 2019